SB-204,070

SB-204070

SB-204070

Chemical compound

SB-204070 is a drug which acts as a potent and selective 5-HT4 serotonin receptor antagonist (or weak partial agonist), and is used for research into the function of this receptor subtype.[1][2][3][4][5]

Quick Facts Identifiers, CAS Number ...

References

  1. [1]
    Mialet J, Berque-Bestel I, Sicsic S, Langlois M, Fischmeister R, Lezoualc'h F (October 2000). "Pharmacological characterization of the human 5-HT(4(d)) receptor splice variant stably expressed in Chinese hamster ovary cells". British Journal of Pharmacology. 131 (4): 827–35. doi:10.1038/sj.bjp.0703641. PMC 1572397. PMID 11030734.
  2. [2]
    Pindon A, van Hecke G, van Gompel P, Lesage AS, Leysen JE, Jurzak M (January 2002). "Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins". Molecular Pharmacology. 61 (1): 85–96. doi:10.1124/mol.61.1.85. PMID 11752209. S2CID 85908752.
  3. [3]
    Takahashi H, Takada Y, Urano T, Takada A (2002). "5-HT4 receptors in the hippocampus modulate rat locomotor activity". Hippocampus. 12 (3): 304–10. doi:10.1002/hipo.10012. PMID 12099482. S2CID 19746691.
  4. [4]
    Sakurai-Yamashita Y, Yamashita K, Niwa M, Taniyama K (May 2003). "Involvement of 5-hydroxytryptamine4 receptor in the exacerbation of neuronal loss by psychological stress in the hippocampus of SHRSP with a transient ischemia". Brain Research. 973 (1): 92–8. doi:10.1016/S0006-8993(03)02559-9. PMID 12729957. S2CID 22136959.
  5. [5]
    Smith AJ, Chappell AE, Buret AG, Barrett KE, Dong H (December 2006). "5-Hydroxytryptamine contributes significantly to a reflex pathway by which the duodenal mucosa protects itself from gastric acid injury". FASEB Journal. 20 (14): 2486–95. doi:10.1096/fj.06-6391com. PMID 17142798. S2CID 27119792.
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article SB-204,070, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.